2020 annual financial data
Elicio Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -794.72%.
Operating income was -55,273,000 USD and net income was -80,107,000 USD.
Operating cash flow was -22,888,000 USD.
Get free Elicio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,880,000 USD
- Operating income
- -55,273,000 USD
- Net income
- -80,107,000 USD
- Operating cash flow
- -22,888,000 USD